Congressman Robert Aderholt (R-AL04) was one of 14 Republican members of Congress to join in a letter to U.S. Drug Enforcement Administration chief Anne Milgram expressing their opposition to federal rescheduling of marijuana.
While the State of Alabama is in the process of issuing licenses to farmers to grow marijuana and for doctors to recommend it to their patients, it remains a Schedule 1 narcotic with no medicinal value, according to the federal government. There is momentum to change that. The Biden Administration’s Department of Health and Human Services has released a letter urging that marijuana be federally rescheduled, a move that Aderholt opposes.
Aderholt said that he opposes the move even if it is politically popular.
“I am proud to join @PeteSessions and @SenatorLankford in a letter to Administrator Milgram. As Chairman of the Approps Subcommittee on Labor, Health and Human Services, and Education, I share the concern that our nation’s drug policies should not be set based on popular opinion.”
Eight Republican U.S. Senators and six Republican members of the House of Representatives declared the Department of Health and Human Services’ August 29 recommendation to move marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act part of an “irresponsible” “pro-pot agenda.” They urged that marijuana remain listed among the most dangerous drugs.
The letter was sent to Milgram because the decision is now up to her and federal attorneys to consider relevant questions of law and policy in a review of the recommendation by Health and Human Services (HSS).
Chey Garrigan is the founder and CEO of the Alabama Cannabis Industry Association. Garrigan said that marijuana does have documented health benefits and maintains that there are Alabamians who would benefit from medical marijuana.
“Congressman Robert Aderholt can have an opinion,” Garrigan said. “Where is the data that backs up why he is against it?”
“Any effort to reschedule marijuana should be based on proven facts and science – not popular opinion, changes in state laws, or the preferred policy of an administration,” the Republicans, led by Republican Sen. James Lankford (R-Oklahoma) and Representative Pete Sessions (R-Texas) wrote in the September 11 letter to the DEA. “Current research, science, and trends support the case that marijuana should remain a Schedule 1 drug.”
Lankford, Aderholt, and Sessions were joined by Sen. Marsha Blackburn (R-Tennessee), Sen. Ted Budd (R-North Carolina), Sen. Tom Cotton (R-Arkansas), Sen. Mike Crapo (R-Idaho), Sen. Markwayne Mullin (R-Oklahoma), Sen. James Risch (R-Idaho), Sen. M. Michael Rounds (R-South Dakota), Rep. Earl “Buddy” Carter (R-Georgia), Rep. Andy Biggs (R-Arizona), Rep. Chuck Edwards (North Carolina), and Rep. Hal Rogers (R-Kentucky).
Even though Oklahoma has over 7,000 marijuana farms and businesses, Lankford argued in a recent column that marijuana has not befitted Oklahomans.
“Drug cartels—from not just south of the border, but also Asia—are now deeply ingrained across Oklahoma, operating grow facilities that ship marijuana across the country,” Lankford wrote. “Oklahomans often now wake up to read the news about the latest execution-style murder, human trafficking, or prostitution at a grow facility in rural Oklahoma. In January 2023, the Tulsa World reported that about 2,000 licenses for medical marijuana were being investigated because they were suspected of having been either obtained unlawfully or were covering up an operation to sell on the black market. Oklahoma is now the top source for black market marijuana in the nation. So much for the argument that widening legal access to a drug gets rid of the illicit market.”
President Joe Biden launched the first federal administrative review of marijuana’s legal status last October, calling current federal policy a “failed approach.”
To connect with the author of this story or to comment, email brandonmreporter@gmail.com.
